MIRA INFORM REPORT

 

 

Report Date :

18.07.2012

 

IDENTIFICATION DETAILS

 

Name :

BASIC PHARMA LIFE SCIENCE PRIVATE LIMITED

 

 

Registered Office :

Plot No.146/B, GIDC Estate, Opposite Fire Fighter Station, Ankleshwar – 393 002, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

20.06.2005

 

 

Com. Reg. No.:

04-046278

 

 

Capital Investment / Paid-up Capital :

Rs.3.484 Millions

 

 

CIN No.:

[Company Identification No.]

U24230GJ2005PTC046278

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BRDB01634D

 

 

PAN No.:

[Permanent Account No.]

AACCB7672G

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Bulk Drugs, Drug Intermediates and Fine Chemicals.

 

 

No. of Employees :

50 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (46)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 57000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. Trade relations are reported as fair. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.09.2011)

Current Rating

(31.12.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INFORMATION PARTED BY

 

Name :

Mr. Paresh Madhavjibhai Vaghasia

Designation :

Director

Contact No.:

91-9825056886

Date :

16.07.2012

 

 

LOCATIONS

 

Registered Office/ Factory :

Plot No.146/B, GIDC Estate, Opposite Fire Fighter Station, Ankleshwar – 393 002, Gujarat, India

Tel. No.:

91-2646-645714/ 226037

Mobile No.:

91-9825056886 (Mr. Paresh Madhavjibhai Vaghasia)

Tele Fax No.:

91-2646-226037

E-Mail :

basicpharma@gmail.com

basic@basicpharmachem.com

bascipharmachem@hotmail.com

Website :

http://www.basicpharma.diytrade.com

http://www.basicpharmachem.com

Location :

Owned

 

 

DIRECTORS

 

As on 30.09.2011

 

Name :

Mr. Paresh Madhavjibhai Vaghasia

Designation :

Director

Address :

Block No.28, Manorath CHS, GIDC Estate, Ankleshwar – 393 002, Gujarat, India

Date of Appointment :

20.06.2005

DIN No.:

00375578

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24230GJ2005PTC046278

Basic Pharma Life Science Private Limited

Director

20/06/2005

20/06/2005

Active

NO

2

U80903GJ2011PTC063801

Takshshila Vidhyapith Private Limited

Additional director

01/05/2012

01/05/2012

Active

NO

 

 

Name :

Mr. Mahesh Rajabhai Vekaria

Designation :

Director

Address :

Block No.1320, Behind GIL Colony, GIDC New Colony, Anklewshwar – 393 002, Gujarat, India

Date of Appointment :

20.06.2005

DIN No.:

00375493

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24230GJ2005PTC046278

Basic Pharma Life Science Private Limited

Director

20/06/2005

20/06/2005

Active

NO

2

U80903GJ2011PTC063801

Takshshila Vidhyapith Private Limited

Additional director

01/05/2012

01/05/2012

Active

NO

 

 

Name :

Mr. Mukesh Devrajbhai Thummar

Designation :

Director

Address :

Block No.28, Manorath CHS, GIDC Estate, Ankleshwar – 393 002, Gujarat, India

Date of Appointment :

20.06.2005

DIN No.:

00375546

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24230GJ2005PTC046278

Basic Pharma Life Science Private Limited

Director

20/06/2005

20/06/2005

Active

NO

2

U80903GJ2011PTC063801

Takshshila Vidhyapith Private Limited

Additional director

01/05/2012

01/05/2012

Active

NO

 

 

Name :

Mr. Nileshkumar Shantilal Gondaliya

Designation :

Director

Address :

40/246, Near Gatu Vidhyalaya, GIDC New Colony, Ankleshwar – 393 002, Gujarat, India

Date of Appointment :

20.06.2005

DIN No.:

00375608

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24230GJ2005PTC046278

Basic Pharma Life Science Private Limited

Director

20/06/2005

20/06/2005

Active

NO

2

U80903GJ2011PTC063801

Takshshila Vidhyapith Private Limited

Additional director

01/05/2012

01/05/2012

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2011

 

Names of Shareholders

 

No. of Shares

 

Paresh Vaghasla

 

87103

Mahesh Vekaria

 

87103

Nilesh S. Gondaliya

 

87102

Mukesh Thummar

 

87102

Total

 

348410

 

As on 30.09.2011

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Directors or relatives of directors

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Bulk Drugs, Drug Intermediates and Fine Chemicals.

 

 

Products :

v      Chlorhexidine Base

v      Chlorhexidine Gluconate 20% Solution

v      Chlorhexidine Hydrochloride

v      Chlorhexidine Acetate

v      Cetrimide Powder

v      Cetrimide Strong 40% Solution

v      Amlodipine Besilate

v      Glibenclamide

v      Cetyl Pyridinium Chloride

v      Proguanil Hydrochloride

v      Niclosamide 

 

 

Exports :

 

Products :

Bulk Drugs, Drug Intermediates and Fine Chemicals

Countries :

v      USA

v      Germany

v      Turkey

v      Argentina

v      Brazil

v      Chile

v      Peru

 

 

Imports :

 

Products :

Raw Materials

Countries :

v      Switzerland

v      France

v      USA

v      China

 

 

Terms :

 

Selling :

Depends

 

 

Purchasing :

Depends

 

PRODUCTION STATUS (AS ON 31.03.2011)

 

Particulars

2010-2011

 

Licensed Capacity

N.A.

Installed Capacity (In Kgs./ p.a.)

 

Chlorhexidine Base

36000

Chlorhexidine Gluconate

150000

Chlorhexidine Acetate

10000

Chlorhexidine Hcl

10000

Cetrimide Powder

20000

 

 

GENERAL INFORMATION

 

Customers :

Manufacturer

 

 

No. of Employees :

50 (Approximately)

 

 

Bankers :

v      Bank of Baroda, Industrial Estate Branch, GIDC, Ankleshwar - 393 002, Gujarat, India

v      HDFC Bank Limited

v      Kotak Mahindra Bank

v      Barclays Bank Plc

v      Axis Bank Limited, Plot No.C-3/9, Opposite Asopalav Guest House, Near Railway Station, Old N.H. No.8, GIDC, Ankleshwar – 393 002, Gujarat, India

 

 

Facilities :

Secured Loans

31.03.2011

Rs. In Millions

31.03.2010

Rs. In Millions

Term Loan from Bank

 

 

Bank of Baroda-1

0.314

1.099

Bank of Baroda-2

1.331

1.841

Demand Loan

 

 

Barclays Bank Plc

0.365

0.704

Cash Credit

 

 

Bank of Baroda

5.108

6.003

Total

7.118

9.647

 

Note:

Term Loans from Bank of Baroda are secured against Equitable mortgage of factory land and building and Hypothecation of plant and machineries. Cash Credit from Bank of Baroda is secured against Hypothecation of stock, book debts and machineries. Demand Loans are secured against personal guarantee of directors.

 

Unsecured Loans

31.03.2011

Rs. In Millions

31.03.2010

Rs. In Millions

Others

 

 

Shareholders and relatives

5.183

2.863

Outsiders

0.000

1.435

Loans from Directors and Managers

 

 

Directors

0.862

0.778

Total

6.045

5.076

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Rahuldeo and Company

Chartered Accountants

Address :

S-35, Uma Complex, GIDC, Ankleshwar – 393 002, Gujarat, India

Income-tax PAN of auditor or auditor's firm :

AEAPP0126N

 

 

CAPITAL STRUCTURE

 

As on 30.09.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

350000

Equity Shares

Rs.10/- each

Rs.3.500 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

348410

Equity Shares

Rs.10/- each

Rs.3.484 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

3.484

3.484

3.484

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

10.871

3.980

1.588

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

14.355

7.464

5.072

LOAN FUNDS

 

 

 

1] Secured Loans

7.118

9.647

11.078

2] Unsecured Loans

6.045

5.076

5.209

TOTAL BORROWING

13.163

14.723

16.287

DEFERRED TAX LIABILITIES

1.159

0.564

0.444

 

 

 

 

TOTAL

28.677

22.751

21.803

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

28.731

18.673

16.891

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERRED TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

8.388

5.639

6.949

 

Sundry Debtors

8.672

2.234

3.005

 

Cash & Bank Balances

0.625
2.172

1.296

 

Other Current Assets

7.270
4.177

2.459

 

Loans & Advances

4.872
2.015

2.137

Total Current Assets

29.827

16.237

15.846

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

25.247
10.933

10.343

 

Other Current Liabilities

0.000
0.011

(0.022)

 

Provisions

4.651
1.249

0.664

Total Current Liabilities

29.898

12.193

10.985

Net Current Assets

(0.071)
4.044

4.861

 

 

 

 

MISCELLANEOUS EXPENSES

0.017

0.034

0.051

 

 

 

 

TOTAL

28.677

22.751

21.803

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

102.071

53.661

34.291

 

 

Other Income

NA

1.630

0.977

 

 

TOTAL                                    

NA

55.291

35.268

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

NA

52.167

34.291

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

NA

52.167

34.291

 

 

 

 

 

 

PROFIT BEFORE TAX

NA

3.124

0.977

 

 

 

 

 

Less

TAX                                                                 

NA

1.021

0.113

 

 

 

 

 

 

PROFIT AFTER TAX

6.891

2.103

0.864

 

 

 

 

 

 

C.I.F. VALUE OF IMPORTS

16.039

3.390

5.964

 

 

 

 

 

 

Earnings Per Share (Rs.)

19.78

6.04

NA

 

 

Particulars

 

 

 

31.03.2012

Sales Turnover (Approximately)

 

 

140.000

 

 

 

 

 

Expected Sales (2012-2013): Rs.200.000 millions

 

The above information has been parted by Mr. Paresh Madhavjibhai Vaghasia (Director).

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

NA
3.80

2.45

 

 

 
 

 

Net Profit Margin

(PBT/Sales)

(%)

NA
5.82

2.85

 

 

 
 

 

Return on Total Assets

(PBT/Total Assets}

(%)

NA
8.95

2.98

 

 

 
 

 

Return on Investment (ROI)

(PBT/Networth)

 

NA
0.42

0.19

 

 

 
 

 

Debt Equity Ratio

(Total Liability/Networth)

 

3.00
3.61

5.38

 

 

 
 

 

Current Ratio

(Current Asset/Current Liability)

 

1.00
1.33

1.44

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Check List by Info Agents

Available in Report (Yes / No)

1) Year of Establishment

Yes

2) Locality of the firm

Yes

3) Constitutions of the firm

Yes 

4) Premises details

No

5) Type of Business

Yes

6) Line of Business

Yes

7) Promoter’s background

Yes

8) No. of employees

Yes

9) Name of person contacted

Yes

10) Designation of contact person

Yes

11) Turnover of firm for last three years

Yes

12) Profitability for last three years

Yes

13) Reasons for variation <> 20%

--

14) Estimation for coming financial year

Yes

15) Capital in the business

Yes

16) Details of sister concerns

No

17) Major suppliers

No

18) Major customers

No

19) Payments terms

Yes

20) Export / Import details (if applicable)

Yes

21) Market information

--

22) Litigations that the firm / promoter involved in

--

23) Banking Details

Yes

24) Banking facility details

Yes

25) Conduct of the banking account

--

26) Buyer visit details

--

27) Financials, if provided

Yes

28) Incorporation details, if applicable

Yes

29) Last accounts filed at ROC

Yes

30) Major Shareholders, if available

Yes

 

REVIEW OF OPERATION:

 

During the year the Company has achieved turnover of Rs.102.071 millions and has earned Net Profit of Rs.6.891 millions after providing depreciation and tax. The Board of Directors found lucrative chances for the better development in the forthcoming period.

 

Bankers Charges Report as per Registry

 

Corporate identity number of the company

U24230GJ2005PTC046278

Name of the company

BASIC PHARMA LIFE SCIENCE PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

Plot No.146/B, GIDC Estate, Opposite Fire Fighter Station, Ankleshwar – 393 002, Gujarat, India

E-Mail: basicpharma@gmail.com

This form is for

Modification of charge

Charge identification number of the modified 

10296058

Type of charge

Immovable Property

Particular of charge holder

Axis Bank Limited, Plot No.C-3/9, Opposite Asopalav Guest House, Near Railway Station, Old N.H. No.8, GIDC, Ankleshwar – 393 002, Gujarat, India

E-Mail: amit.upadhyay@axisbank.com

Nature of description of the instrument creating or modifying the charge

Equitable mortgage by deposit of title deeds dated 30.08.2011

Date of instrument Creating the charge

30.08.2011

Amount secured by the charge

Rs.36.889 millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest:

Cash Credit and Term Loan: 3.50% (Base rate 9.75% p.a.) Presently 13.25% p.a.

Export Packaging Limit: up 180 days 11.00% p.a. and after 180 days 12.00% p.a.

FBP/FBD : up to 90 days 11.00% p.a.and after 12.00

 

Terms of Repayment:

Cash Credit :  On demand

Term Loan I  : 26 monthly installments

Term Loan II : 48 monthly installments

 

Margin:

Cash Credit: 25% on stock and 40% on receivables

Term Loan I : N.A

Term Loan II: 25.93% of cost of plant and machineries.

FBP/FBD Limit : N.A

ILC/FLC Limit and Buyers Credit and Bank Guarantee : 15% of cash margin

LER : 100% of cash margin

 

Extent and Operation of the charge:

Till the full repayment.

Short particulars of the property charged

Vllage Piraman R S No. 241 paiki industrial Plot No. 146/B, adm 4922 sq. mts., District: Bharuch, Sub-District Ankleshwar.

Particulars of the present modification 

Immovable property situated at Vllage Piraman R.S. No.241 paiki industrial Plot No.146/B, adm 4922 sq. mts., District: Bharuch, Sub-District Ankleshwar have been  provided to secured the loan amount of Rs.36.889 millions  by way of Equitable Mortgage by deposit of title deeds dated 30.08.2011.

 

FIXED ASSETS:

 

v      Factory Building

v      Leasehold Land

v      Vehicles

v      Plant and Machinery

v      Laboratory Equipments

v      Electrical Installations

v      Diesel Generator Set

v      Weighing Scale

v      Gas Pipeline Heating System

v      Office Equipments

v      Computer

v      Printer

v      Furniture and Fixtures

v      Refrigerator 

v      Mobile Phones

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.55.15

UK Pound

1

Rs.86.30

Euro

1

Rs.67.73

 

 

INFORMATION DETAILS

 

Information Gathered by :

SBA

 

 

Report Prepared by :

SMN


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

46

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.